Cognitive Therapy for Social Anxiety Disorder: Comparison between interventions based on self-worthy improvement and interventions based on experience
Phase 4
Recruiting
- Conditions
- F40.1Social phobias
- Registration Number
- DRKS00014349
- Lead Sponsor
- Goethe Universität FrankfurtInstitut für PsychologieKlinische Psychologie und Psychotherapie
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- All
- Target Recruitment
- 60
Inclusion Criteria
primary diagnosis: Social Phobia
Exclusion Criteria
acute suicidality, active substance abuse or dependence within the past 3 months, severe depression ((HRSD score >23), psychotic disorder, bipolar disorder, borderline personality disorder, organic mental disorder and/or severe medical conditions, parallel ongoing other psychotherapy or medical treatment
Study & Design
- Study Type
- interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Completion of Shortterm-therapy (25 sessions)<br><br>messuarements at post-treatment: symptoms of Social Phobia with LSAS = Liebowitz Social Anxiety Scale und SPIN = Social Phobia Inventory<br>messuarements at 6 month follow up: symptoms of Social Phobia with LSAS = Liebowitz Social Anxiety Scale und SPIN = Social Phobia Inventory
- Secondary Outcome Measures
Name Time Method
Related Research Topics
Explore scientific publications, clinical data analysis, treatment approaches, and expert-compiled information related to the mechanisms and outcomes of this trial. Click any topic for comprehensive research insights.
What molecular mechanisms underlie cognitive therapy for F40.1 social phobias in DRKS00014349?
How does self-worthy improvement compare to exposure-based CBT for social anxiety disorder outcomes?
Are there specific biomarkers that predict response to cognitive interventions in social phobia trials?
What adverse events are associated with cognitive therapy approaches for social anxiety disorder?
How does DRKS00014349's intervention compare to SSRIs or SNRIs in treating social phobia symptoms?